Specimens for Lung Cancer Panel Design

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Maverix Medical
Study ID
NCT07401797
Status
Recruiting
Apply to this trial

Conditions

  • Lung Nodules

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.

Key Dates

Start date
Aug 7, 2024
Status verified
Jan 2026
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Prior cancer
    Prior cancer history
  • Arm: No prior cancer
    Indeterminant lung nodules with no prior history of cancer
  • Arm: Healthy volunteers
    Healthy volunteers

Primary Outcome Measure

Test performance [ Time Frame: Two years from final case enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Maverix MedicalPhoenixArizona85004
David Mallery
[email protected]
858-245-4239
Scott Morris, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

By research site
Maverix Medical· Phoenix, AZ

Related Studies